{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:12:44Z","timestamp":1648753964722},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00103-017-2630-x","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T11:40:38Z","timestamp":1505821238000},"page":"1261-1268","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beigebrauchdetektion in der Substitutionstherapie"],"prefix":"10.1007","volume":"60","author":[{"given":"Johannes","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Geraedts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"2630_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","volume":"19","author":"EF Mccance-Katz","year":"2010","unstructured":"Mccance-Katz EF, Sullivan LE, Nallani S (2010) Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a\u00a0review. Am J Addict 19:4\u201316","journal-title":"Am J Addict"},{"key":"2630_CR2","volume-title":"Pressekonferenz der Drogenbeauftragten der Bundesregierung und des Pr\u00e4sidenten des Bundeskriminalamtes; Zahl der Drogentoten\/Rauschgiftlage 2014","author":"Bundesregierung und Bundeskriminalamt","year":"2015","unstructured":"Bundesregierung und Bundeskriminalamt (2015) Pressekonferenz der Drogenbeauftragten der Bundesregierung und des Pr\u00e4sidenten des Bundeskriminalamtes; Zahl der Drogentoten\/Rauschgiftlage 2014. \n                        http:\/\/www.jes-bundesverband.de\/uploads\/media\/Presseinfo_Drogentote_2014.pdf\n                        \n                    . Zugegriffen: 14. Dez. 2016"},{"key":"2630_CR3","volume-title":"Anzahl der Drogentoten nach ausgew\u00e4hlten Todesursachen in Deutschland in den Jahren 2007 bis 2014","author":"Bundeskriminalamt","year":"2015","unstructured":"Bundeskriminalamt (2015) Anzahl der Drogentoten nach ausgew\u00e4hlten Todesursachen in Deutschland in den Jahren 2007 bis 2014. \n                        http:\/\/de.statista.com\/statistik\/daten\/studie\/187669\/umfrage\/drogentote-in-deutschland-nach-todesursache\/\n                        \n                    . Zugegriffen: 14. Dez. 2016"},{"key":"2630_CR4","volume-title":"Richtlinien der Bundes\u00e4rztekammer zur Durchf\u00fchrung der substitutionsgest\u00fctzten Behandlung Opiatabh\u00e4ngiger","author":"Bundes\u00e4rztekammer","year":"2010","unstructured":"Bundes\u00e4rztekammer (2010) Richtlinien der Bundes\u00e4rztekammer zur Durchf\u00fchrung der substitutionsgest\u00fctzten Behandlung Opiatabh\u00e4ngiger. \n                        http:\/\/www.bundesaerztekammer.de\/downloads\/RL-Substitution_19-Februar-2010.pdf\n                        \n                    . Zugegriffen: 16. Dez. 2016"},{"key":"2630_CR5","first-page":"200","volume":"13","author":"HU Wittchen","year":"2011","unstructured":"Wittchen HU, B\u00fchringer G, Rehm J (2011) Effekte der langfristigen Substitution Opioidabh\u00e4ngiger: Pr\u00e4dikotren, Moderatoren und Outcome. Suchtmed Forsch Prax 13:200\u2013300","journal-title":"Suchtmed Forsch Prax"},{"key":"2630_CR6","first-page":"405","volume":"110","author":"S Gutwinski","year":"2013","unstructured":"Gutwinski S, Bald LK, Heinz A et\u00a0al (2013) Take home maintenance medication in opiate dependence. Dtsch Arztebl Int 110:405\u2013412","journal-title":"Dtsch Arztebl Int"},{"key":"2630_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PEC.0b013e318196faff","volume":"25","author":"M Glatstein","year":"2009","unstructured":"Glatstein M, Finkelstein Y, Scolnik D (2009) Accidental methadone ingestion in an infant: case report and review of the literature. Pediatr Emerg Care 25:109\u2013111","journal-title":"Pediatr Emerg Care"},{"key":"2630_CR8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0379-0738(00)00282-6","volume":"113","author":"A Heinemann","year":"2000","unstructured":"Heinemann A, Iwersen-Bergmann S, Stein S, Schmoldt A, Puschel K (2000) Methadone-related fatalities in Hamburg 1990\u20131999: implications for quality standards in maintenance treatment? Forensic Sci Int 113:449\u2013455","journal-title":"Forensic Sci Int"},{"key":"2630_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","volume":"98","author":"M Gossop","year":"2003","unstructured":"Gossop M, Marsden J, Stewart D, Kidd T (2003) The National Treatment Outcome Research Study (NTORS): 4\u20135 year follow-up results. Addiction 98:291\u2013303","journal-title":"Addiction"},{"key":"2630_CR10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1258\/acb.2011.011116","volume":"48","author":"KR Allen","year":"2011","unstructured":"Allen KR (2011) Screening for drugs of abuse: which matrix, oral fluid or urine? Ann Clin Biochem 48:531\u2013541","journal-title":"Ann Clin Biochem"},{"key":"2630_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","volume":"26","author":"AG Verstraete","year":"2004","unstructured":"Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26:200\u2013205","journal-title":"Ther Drug Monit"},{"key":"2630_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2012.01.001","volume":"219","author":"V Vindenes","year":"2012","unstructured":"Vindenes V, Lund HM, Andresen W et\u00a0al (2012) Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci Int 219:165\u2013171","journal-title":"Forensic Sci Int"},{"key":"2630_CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/FQY06F8XKTQPM149","volume":"128","author":"A Dasgupta","year":"2007","unstructured":"Dasgupta A (2007) The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. Am J Clin Pathol 128:491\u2013503","journal-title":"Am J Clin Pathol"},{"key":"2630_CR14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00007691-200312000-00011","volume":"25","author":"AD Fraser","year":"2003","unstructured":"Fraser AD, Zamecnik J (2003) Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators. Ther Drug Monit 25:723\u2013727","journal-title":"Ther Drug Monit"},{"key":"2630_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0036933013482640","volume":"58","author":"CA Maccall","year":"2013","unstructured":"Maccall CA, Ritchie G, Sood M (2013) Oral fluid testing as an alternative to urine testing for drugs of abuse in inpatient forensic settings: giving patients choice. Scott Med\u00a0J 58:99\u2013103","journal-title":"Scott Med J"},{"key":"2630_CR16","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1373\/clinchem.2008.108670","volume":"55","author":"WM Bosker","year":"2009","unstructured":"Bosker WM, Huestis MA (2009) Oral fluid testing for drugs of abuse. Clin Chem 55:1910\u20131931","journal-title":"Clin Chem"},{"key":"2630_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","volume":"150","author":"DJ Crouch","year":"2005","unstructured":"Crouch DJ (2005) Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int 150:165\u2013173","journal-title":"Forensic Sci Int"},{"key":"2630_CR18","first-page":"147","volume":"27","author":"OH Drummer","year":"2006","unstructured":"Drummer OH (2006) Drug testing in oral fluid. Clin Biochem Rev 27:147\u2013159","journal-title":"Clin Biochem Rev"},{"key":"2630_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4155\/bio.09.23","volume":"1","author":"E Gallardo","year":"2009","unstructured":"Gallardo E, Barroso M, Queiroz JA (2009) Current technologies and considerations for drug bioanalysis in oral fluid. Bioanalysis 1:637\u2013667","journal-title":"Bioanalysis"},{"key":"2630_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/FTD.0b013e318167d563","volume":"30","author":"K Pil","year":"2008","unstructured":"Pil K, Verstraete A (2008) Current developments in drug testing in oral fluid. Ther Drug Monit 30:196\u2013202","journal-title":"Ther Drug Monit"},{"key":"2630_CR21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jat\/bkr019","volume":"36","author":"R Heltsley","year":"2012","unstructured":"Heltsley R, Depriest A, Black DL et\u00a0al (2012) Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. J\u00a0Anal Toxicol 36:75\u201380","journal-title":"J Anal Toxicol"},{"key":"2630_CR22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jat\/30.7.478","volume":"30","author":"BE Smink","year":"2006","unstructured":"Smink BE, Mathijssen MP, Lusthof KJ, De Gier JJ, Egberts AC, Uges DR (2006) Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS). J\u00a0Anal Toxicol 30:478\u2013485","journal-title":"J Anal Toxicol"},{"key":"2630_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.forsciint.2004.08.002","volume":"152","author":"SW Toennes","year":"2005","unstructured":"Toennes SW, Kauert GF, Steinmeyer S, Moeller MR (2005) Driving under the influence of drugs\u2014evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int 152:149\u2013155","journal-title":"Forensic Sci Int"},{"key":"2630_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/anatox\/35.1.32","volume":"35","author":"V Vindenes","year":"2011","unstructured":"Vindenes V, Yttredal B, Oiestad EL et al (2011) Oral fluid is a\u00a0viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine. J\u00a0Anal Toxicol 35:32\u201339","journal-title":"J Anal Toxicol"},{"key":"2630_CR25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1373\/clinchem.2011.164822","volume":"57","author":"D Lee","year":"2011","unstructured":"Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA (2011) Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Clin Chem 57:1127\u20131136","journal-title":"Clin Chem"},{"key":"2630_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jat\/25.5.289","volume":"25","author":"RS Niedbala","year":"2001","unstructured":"Niedbala RS, Kardos KW, Fritch DF et al (2001) Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J\u00a0Anal Toxicol 25:289\u2013303","journal-title":"J Anal Toxicol"},{"key":"2630_CR27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jat\/28.6.394","volume":"28","author":"MA Huestis","year":"2004","unstructured":"Huestis MA, Cone EJ (2004) Relationship of Delta 9\u2011tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J\u00a0Anal Toxicol 28:394\u2013399","journal-title":"J Anal Toxicol"},{"key":"2630_CR28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/dta.1514","volume":"6","author":"D Lee","year":"2014","unstructured":"Lee D, Huestis MA (2014) Current knowledge on cannabinoids in oral fluid. Drug Test Anal 6:88\u2013111","journal-title":"Drug Test Anal"},{"key":"2630_CR29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","volume":"105","author":"RH Lowe","year":"2009","unstructured":"Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA (2009) Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a\u00a0biomarker of new drug exposure. Drug Alcohol Depend 105:24\u201332","journal-title":"Drug Alcohol Depend"},{"key":"2630_CR30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jat\/28.7.546","volume":"28","author":"S Niedbala","year":"2004","unstructured":"Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ (2004) Passive cannabis smoke exposure and oral fluid testing. J\u00a0Anal Toxicol 28:546\u2013552","journal-title":"J Anal Toxicol"},{"key":"2630_CR31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jat\/31.9.596","volume":"31","author":"C Moore","year":"2007","unstructured":"Moore C, Coulter C, Crompton K, Zumwalt M (2007) Determination of benzodiazepines in oral fluid using LC-MS-MS. J\u00a0Anal Toxicol 31:596\u2013600","journal-title":"J Anal Toxicol"},{"key":"2630_CR32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jat\/26.4.211","volume":"26","author":"N Samyn","year":"2002","unstructured":"Samyn N, De Boeck G, Cirimele V, Verstraete A, Kintz P (2002) Detection of flunitrazepam and 7\u2011aminoflunitrazepam in oral fluid after controlled administration of rohypnol. J\u00a0Anal Toxicol 26:211\u2013215","journal-title":"J Anal Toxicol"},{"key":"2630_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsat.2010.05.007","volume":"39","author":"CM Comiskey","year":"2010","unstructured":"Comiskey CM, Cox G (2010) Analysis of the impact of treatment setting on outcomes from methadone treatment. J\u00a0Subst Abuse Treat 39:195\u2013201","journal-title":"J Subst Abuse Treat"},{"key":"2630_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jsat.2008.11.004","volume":"37","author":"KF Corsi","year":"2009","unstructured":"Corsi KF, Lehman WK, Booth RE (2009) The effect of methadone maintenance on positive outcomes for opiate injection drug users. J\u00a0Subst Abuse Treat 37:120\u2013126","journal-title":"J Subst Abuse Treat"},{"key":"2630_CR35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jsat.2005.08.002","volume":"29","author":"A Dobler-Mikola","year":"2005","unstructured":"Dobler-Mikola A, Hattenschwiler J, Meili D, Beck T, Boni E, Modestin J (2005) Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J\u00a0Subst Abuse Treat 29:259\u2013265","journal-title":"J Subst Abuse Treat"},{"key":"2630_CR36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsat.2013.12.004","volume":"47","author":"SG Sullivan","year":"2014","unstructured":"Sullivan SG, Wu Z, Cao X, Liu E, Detels R, National Methadone Maintenance Treatment Working G (2014) Continued drug use during methadone treatment in China: a\u00a0retrospective analysis of 19,026 service users. J\u00a0Subst Abuse Treat 47:86\u201392","journal-title":"J Subst Abuse Treat"},{"key":"2630_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4","author":"RP Mattick","year":"2014","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. \n                        https:\/\/doi.org\/10.1002\/14651858.CD002207.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2630_CR38","first-page":"1","volume":"11","author":"M Connock","year":"2007","unstructured":"Connock M, Juarez-Garcia A, Jowett S et al (2007) Methadone and buprenorphine for the management of opioid dependence: a\u00a0systematic review and economic evaluation. Health Technol Assess 11:1\u2013171","journal-title":"Health Technol Assess"},{"key":"2630_CR39","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bcp.12031","volume":"77","author":"MP Garcia-Portilla","year":"2014","unstructured":"Garcia-Portilla MP, Bobes-Bascaran MT, Bascaran MT, Saiz PA, Bobes J (2014) Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? Br J Clin Pharmacol 77:272\u2013284","journal-title":"Br J Clin Pharmacol"},{"key":"2630_CR40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0376-8716(97)00099-9","volume":"47","author":"DD Simpson","year":"1997","unstructured":"Simpson DD, Joe GW, Rowan-Szal GA (1997) Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend 47:227\u2013235","journal-title":"Drug Alcohol Depend"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-017-2630-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-017-2630-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-017-2630-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T09:01:15Z","timestamp":1530003675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-017-2630-x"}},"subtitle":["Speichelproben versus Urinscreening"],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1007\/s00103-017-2630-x","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]}}}